Zikavaccine.com

Zikavaccine.com has Server used 141.8.225.75 IP Address with Hostname in Switzerland. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2016-01-17 (4 years, 202 days) and hosted in Switzerland, server ping response time 58 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Zikavaccine keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Zika vaccine
2 Zika vaccine ade
3 Zika vaccine cdc
4 Zika vaccine nih
5 Zika vaccine 2018
6 Zika vaccine 2019
7 Zika vaccine news
8 Zika vaccine status
9 Zika vaccine company

Hosting Provider

Website: Zikavaccine.com
Hostname: 141.8.225.75
Country:
Latitude: 47.144901275635
Longitude: 8.1550998687744
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Muddlaw.net (11 seconds ago)

   » Dressme2night.com (1 seconds ago)

   » Qcndt.net (1 seconds ago)

   » Kaiotang.com (3 seconds ago)

   » Sflow.org (2 seconds ago)

   » Itsybitsykitchen.com (0 seconds ago)

   » Okrsoftware.com (2 seconds ago)

   » Supco.com (3 seconds ago)

   » Blacktiejazz.com (0 seconds ago)

   » Infohelp.com (7 seconds ago)

Results For Websites Listing

Found 76 Websites with content related to this domain, It is result after search with search engine

Zika Virus Vaccines | NIH: National Institute of Allergy

(3 day ago) If the Zika vaccine candidate proves safe, scientists plan to add the Zika component to the dengue vaccine candidate to create and evaluate a single vaccine that would protect against both Zika and all four dengue viruses. Investigational mRNA vaccines (a gene-based platform similar to DNA vaccines).

https://www.niaid.nih.gov/diseases-conditions/zika-vaccines

DA: 17 PA: 34 MOZ Rank: 51

Breakthrough in Zika virus vaccine -- ScienceDaily

(11 day ago) A Zika Vaccine Could Virtually Eliminate Prenatal Infections, Model Shows Apr. 2, 2018 — A Zika vaccine could have a substantial effect on mitigating and preventing future Zika virus outbreaks.

https://www.sciencedaily.com/releases/2019/12/191213115442.htm

DA: 20 PA: 34 MOZ Rank: 54

WHO | Zika virus vaccine product development

(3 day ago) WHO/UNICEF Zika Vaccine TPP updated February 2017 pdf, 243kb; Questions and answers on Zika Vaccine TPP pdf, 112kb; In 2018 -2019, WHO in collaboration with a working group of independent subject matter experts developed Preferred Product Characteristics (PPC) for a Zika virus vaccine for endemic use.

https://www.who.int/immunization/research/development/zika/en/

DA: 11 PA: 43 MOZ Rank: 54

NIH-developed Zika vaccine improves fetal outcomes in

(3 day ago) What. An experimental Zika vaccine lowered levels of virus in pregnant monkeys and improved fetal outcomes in a rhesus macaque model of congenital Zika virus infection, according to a new study in Science Translational Medicine.The research was conducted by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and their

https://www.nih.gov/news-events/news-releases/nih-developed-zika-vaccine-improves-fetal-outcomes-animal-model

DA: 11 PA: 50 MOZ Rank: 50

New Data on Moderna's Zika Vaccine Could Raise Hopes for

(5 day ago) The Zika vaccine is Moderna’s seventh to return positive data in a Phase 1 trial. In an interview on Monday, Moderna’s CEO, Stéphane Bancel, said that the positive experience with Moderna’s

https://www.nasdaq.com/articles/new-data-on-modernas-zika-vaccine-could-raise-hopes-for-covid-19-vaccine-2020-04-14

DA: 14 PA: 50 MOZ Rank: 50

NIH Begins Clinical Trial of Live, Attenuated Zika Vaccine

(2 day ago) Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial will enroll a total of 28 healthy, non-pregnant adults ages 18 to 50 at the Johns Hopkins Bloomberg School of Public Health Center for

https://www.niaid.nih.gov/news-events/nih-begins-clinical-trial-live-attenuated-zika-vaccine

DA: 17 PA: 50 MOZ Rank: 84

WHO | Progress toward discovery of Zika virus vaccines and

(8 day ago) The 2015–2016 outbreak of Zika virus disease in the Region of the Americas demonstrated how a relatively obscure and mild mosquito-borne disease can become a global health emergency, causing congenital Zika syndrome, including microcephaly, and neurological complications such as Guillain-Barré syndrome.

https://www.who.int/emergencies/diseases/zika/discovery-of-vaccines/en/

DA: 11 PA: 50 MOZ Rank: 63

NIH begins clinical trial of live, attenuated Zika vaccine

(6 day ago) Once the Zika vaccine candidate proves safe in Phase 1 clinical testing, Dr. Whitehead plans to add the Zika component to the tetravalent dengue vaccine candidate and evaluate the new pentavalent candidate in a Phase 1 clinical trial. Anna Durbin, M.D., professor of International Health at the Johns Hopkins Bloomberg School of Public Health and

https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-live-attenuated-zika-vaccine

DA: 11 PA: 50 MOZ Rank: 92

Zika Virus | CDC

(3 day ago) In 2018 and 2019, no local mosquito-borne Zika virus transmission has been reported in the continental United States. If you are traveling outside of the continental United States, see Zika Travel Information to learn about your destination.. Prevent mosquito bites when traveling:. Use Environmental Protection Agency (EPA)-registered insect repellent to protect yourself and your family from

https://www.cdc.gov/zika/index.html

DA: 11 PA: 16 MOZ Rank: 27

Recently Analyzed Sites